"World's Most Complete Market Research Reports Repository"

Global Anti-Migraine Drugs Market Size, Status and Forecast 2025

This report studies the global Anti-Migraine Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Anti-Migraine Drugs market by companies, region, type and end-use industry.

In 2017, the global Anti-Migraine Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered
Eli Lilly
Abbott Laboratories
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Triptans
Ergots
Others

Market segment by Application, split into
Women
Men

The study objectives of this report are:
To study and forecast the market size of Anti-Migraine Drugs in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Migraine Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anti-Migraine Drugs Manufacturers
Anti-Migraine Drugs Distributors/Traders/Wholesalers
Anti-Migraine Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anti-Migraine Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Anti-Migraine Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Anti-Migraine Drugs
1.1 Anti-Migraine Drugs Market Overview
1.1.1 Anti-Migraine Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Anti-Migraine Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Anti-Migraine Drugs Market by Type
1.3.1 Triptans
1.3.2 Ergots
1.3.3 Others
1.4 Anti-Migraine Drugs Market by End Users/Application
1.4.1 Women
1.4.2 Men

2 Global Anti-Migraine Drugs Competition Analysis by Players
2.1 Anti-Migraine Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Eli Lilly
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.2 Abbott Laboratories
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.3 Eisai
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.4 Allergan
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.5 Endo
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.6 GlaxoSmithKline
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.7 Impax Laboratories
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.8 Pfizer
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.9 AstraZeneca
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.10 Bayer
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Anti-Migraine Drugs Revenue (Million USD) (2013-2018)
3.11 Johnson & Johnson
3.12 Merck
3.13 Teva
3.14 Amgen

4 Global Anti-Migraine Drugs Market Size by Type and Application (2013-2018)
4.1 Global Anti-Migraine Drugs Market Size by Type (2013-2018)
4.2 Global Anti-Migraine Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Anti-Migraine Drugs in Future
4.4 Top Consumer/End Users of Anti-Migraine Drugs

5 United States Anti-Migraine Drugs Development Status and Outlook
5.1 United States Anti-Migraine Drugs Market Size (2013-2018)
5.2 United States Anti-Migraine Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Anti-Migraine Drugs Market Size by Application (2013-2018)

6 Europe Anti-Migraine Drugs Development Status and Outlook
6.1 Europe Anti-Migraine Drugs Market Size (2013-2018)
6.2 Europe Anti-Migraine Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Anti-Migraine Drugs Market Size by Application (2013-2018)

7 China Anti-Migraine Drugs Development Status and Outlook
7.1 China Anti-Migraine Drugs Market Size (2013-2018)
7.2 China Anti-Migraine Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Anti-Migraine Drugs Market Size by Application (2013-2018)

8 Japan Anti-Migraine Drugs Development Status and Outlook
8.1 Japan Anti-Migraine Drugs Market Size (2013-2018)
8.2 Japan Anti-Migraine Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Anti-Migraine Drugs Market Size by Application (2013-2018)

9 Southeast Asia Anti-Migraine Drugs Development Status and Outlook
9.1 Southeast Asia Anti-Migraine Drugs Market Size (2013-2018)
9.2 Southeast Asia Anti-Migraine Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Anti-Migraine Drugs Market Size by Application (2013-2018)

10 India Anti-Migraine Drugs Development Status and Outlook
10.1 India Anti-Migraine Drugs Market Size (2013-2018)
10.2 India Anti-Migraine Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Anti-Migraine Drugs Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Anti-Migraine Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Anti-Migraine Drugs Revenue and Growth Rate (2018-2025)
11.1.2 Europe Anti-Migraine Drugs Revenue and Growth Rate (2018-2025)
11.1.3 China Anti-Migraine Drugs Revenue and Growth Rate (2018-2025)
11.1.4 Japan Anti-Migraine Drugs Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Anti-Migraine Drugs Revenue and Growth Rate (2018-2025)
11.1.6 India Anti-Migraine Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Anti-Migraine Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Anti-Migraine Drugs Market Size by Application (2018-2025)

12 Anti-Migraine Drugs Market Dynamics
12.1 Anti-Migraine Drugs Market Opportunities
12.2 Anti-Migraine Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Anti-Migraine Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Anti-Migraine Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Global Anti-Migraine Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Anti-Migraine Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Anti-Migraine Drugs Market Share by Regions (2013-2018)
Figure United States Anti-Migraine Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Anti-Migraine Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Anti-Migraine Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Anti-Migraine Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Anti-Migraine Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Anti-Migraine Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Anti-Migraine Drugs Revenue Market Share by Type in 2017
Figure Triptans Market Size (Million USD) and Growth Rate (2013-2018)
Figure Ergots Market Size (Million USD) and Growth Rate (2013-2018)
Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Anti-Migraine Drugs Market Share by Application in 2017
Figure Anti-Migraine Drugs Market Size (Million USD) and Growth Rate in Women (2013-2018)
Figure Anti-Migraine Drugs Market Size (Million USD) and Growth Rate in Men (2013-2018)
Figure Anti-Migraine Drugs Market Size (Million USD) and Growth Rate in Applications 3 (2013-2018)
Table Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure Anti-Migraine Drugs Market Size Share by Players in 2013
Figure Anti-Migraine Drugs Market Size Share by Players in 2017
Table Eli Lilly Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Abbott Laboratories Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Abbott Laboratories (2013-2018)
Figure Abbott Laboratories Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Eisai Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Eisai (2013-2018)
Figure Eisai Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Allergan Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Allergan (2013-2018)
Figure Allergan Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Endo Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Endo (2013-2018)
Figure Endo Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Impax Laboratories Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Impax Laboratories (2013-2018)
Figure Impax Laboratories Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Bayer Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Anti-Migraine Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Anti-Migraine Drugs Business Revenue Market Share (2013-2018)
Table Teva Basic Information List
Table Amgen Basic Information List
Table Global Anti-Migraine Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Anti-Migraine Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Anti-Migraine Drugs Market Share by Product in 2017
Table Global Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure Global Anti-Migraine Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Anti-Migraine Drugs
Figure United States Anti-Migraine Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Anti-Migraine Drugs Market Size Share by Players in 2013
Figure United States Anti-Migraine Drugs Market Size Share by Players in 2017
Table United States Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure United States Anti-Migraine Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Anti-Migraine Drugs Market Size Share by Application in 2017
Figure Europe Anti-Migraine Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Anti-Migraine Drugs Market Size Share by Players in 2013
Figure Europe Anti-Migraine Drugs Market Size Share by Players in 2017
Table Europe Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure Europe Anti-Migraine Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Anti-Migraine Drugs Market Size Share by Application in 2017
Figure China Anti-Migraine Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Anti-Migraine Drugs Market Size Share by Players in 2013
Figure China Anti-Migraine Drugs Market Size Share by Players in 2017
Table China Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure China Anti-Migraine Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Anti-Migraine Drugs Market Size Share by Application in 2017
Figure Japan Anti-Migraine Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Anti-Migraine Drugs Market Size Share by Players in 2013
Figure Japan Anti-Migraine Drugs Market Size Share by Players in 2017
Table Japan Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure Japan Anti-Migraine Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Anti-Migraine Drugs Market Size Share by Application in 2017
Figure Southeast Asia Anti-Migraine Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Anti-Migraine Drugs Market Size Share by Players in 2013
Figure Southeast Asia Anti-Migraine Drugs Market Size Share by Players in 2017
Table Southeast Asia Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Anti-Migraine Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Anti-Migraine Drugs Market Size Share by Application in 2017
Figure India Anti-Migraine Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Anti-Migraine Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Anti-Migraine Drugs Market Size Share by Players in 2013
Figure India Anti-Migraine Drugs Market Size Share by Players in 2017
Table India Anti-Migraine Drugs Market Size by Application (2013-2018)
Figure India Anti-Migraine Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Anti-Migraine Drugs Market Size Share by Application in 2017
Figure Global Anti-Migraine Drugs Market Size and Growth Rate (2018-2025)
Table Global Anti-Migraine Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Anti-Migraine Drugs Market Size Share (2018-2025)
Figure Global Anti-Migraine Drugs Market Size Share by Regions in 2025
Figure United States Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Anti-Migraine Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Anti-Migraine Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Anti-Migraine Drugs Market Size Share by Type in 2018
Figure Global Anti-Migraine Drugs Market Size Share by Type in 2025
Table Global Anti-Migraine Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Anti-Migraine Drugs Market Size (Million USD) by Application in 2018

Choose License Type